Y.H. Huang

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.

A. Zhou, T. Sun, X.Q. Yan, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Unified approach for rough phase measurement without phase unwrapping by changing the sensitivity factor

Y. Y. Hung, Y. H. Huang, L. Liu, 2009 .